vs
APPIAN CORP（APPN）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是APPIAN CORP的1.0倍（$207.3M vs $202.9M），APPIAN CORP净利率更高（-2.5% vs -62.0%，领先59.5%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 21.7%），APPIAN CORP自由现金流更多（$270.0K vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 16.4%）
Appian是总部位于美国弗吉尼亚州麦克莱恩的云计算与企业软件厂商，身处杜勒斯科技走廊产业带。公司提供平台即服务（PaaS）产品，支持企业级软件开发，业务覆盖北美、欧洲、中东及东南亚市场，深耕低代码开发、流程挖掘、业务流程管理和案例管理领域。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
APPN vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.9M | $207.3M |
| 净利润 | $-5.1M | $-128.6M |
| 毛利率 | 64.8% | — |
| 营业利润率 | -0.3% | -54.7% |
| 净利率 | -2.5% | -62.0% |
| 营收同比 | 21.7% | 25.9% |
| 净利润同比 | 62.6% | 3.5% |
| 每股收益（稀释后） | $-0.06 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $202.9M | $207.3M | ||
| Q3 25 | $187.0M | $159.9M | ||
| Q2 25 | $170.6M | $166.5M | ||
| Q1 25 | $166.4M | $139.3M | ||
| Q4 24 | $166.7M | $164.6M | ||
| Q3 24 | $154.1M | $139.5M | ||
| Q2 24 | $146.4M | $147.0M | ||
| Q1 24 | $149.8M | $108.8M |
| Q4 25 | $-5.1M | $-128.6M | ||
| Q3 25 | $7.8M | $-180.4M | ||
| Q2 25 | $-312.0K | $-115.0M | ||
| Q1 25 | $-1.2M | $-151.1M | ||
| Q4 24 | $-13.6M | $-133.2M | ||
| Q3 24 | $-2.1M | $-133.5M | ||
| Q2 24 | $-43.6M | $-131.6M | ||
| Q1 24 | $-32.9M | $-170.7M |
| Q4 25 | 64.8% | — | ||
| Q3 25 | 75.8% | — | ||
| Q2 25 | 74.3% | — | ||
| Q1 25 | 76.6% | — | ||
| Q4 24 | 67.8% | — | ||
| Q3 24 | 75.9% | — | ||
| Q2 24 | 73.1% | — | ||
| Q1 24 | 74.6% | — |
| Q4 25 | -0.3% | -54.7% | ||
| Q3 25 | 7.0% | -106.9% | ||
| Q2 25 | -6.4% | -64.8% | ||
| Q1 25 | -0.5% | -102.6% | ||
| Q4 24 | 3.0% | -74.3% | ||
| Q3 24 | -4.6% | -94.6% | ||
| Q2 24 | -26.8% | -79.1% | ||
| Q1 24 | -13.0% | -151.9% |
| Q4 25 | -2.5% | -62.0% | ||
| Q3 25 | 4.2% | -112.8% | ||
| Q2 25 | -0.2% | -69.0% | ||
| Q1 25 | -0.7% | -108.5% | ||
| Q4 24 | -8.2% | -80.9% | ||
| Q3 24 | -1.4% | -95.7% | ||
| Q2 24 | -29.8% | -89.5% | ||
| Q1 24 | -22.0% | -156.8% |
| Q4 25 | $-0.06 | $-1.28 | ||
| Q3 25 | $0.10 | $-1.81 | ||
| Q2 25 | $0.00 | $-1.17 | ||
| Q1 25 | $-0.02 | $-1.57 | ||
| Q4 24 | $-0.18 | $-1.34 | ||
| Q3 24 | $-0.03 | $-1.40 | ||
| Q2 24 | $-0.60 | $-1.52 | ||
| Q1 24 | $-0.45 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $187.2M | $421.0M |
| 总债务越低越好 | $240.8M | — |
| 股东权益账面价值 | $-47.0M | $-80.0M |
| 总资产 | $691.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $187.2M | $421.0M | ||
| Q3 25 | $191.6M | $202.5M | ||
| Q2 25 | $184.8M | $176.3M | ||
| Q1 25 | $199.7M | $127.1M | ||
| Q4 24 | $159.9M | $174.0M | ||
| Q3 24 | $99.2M | $150.6M | ||
| Q2 24 | $120.8M | $480.7M | ||
| Q1 24 | $170.1M | $112.3M |
| Q4 25 | $240.8M | — | ||
| Q3 25 | $245.7M | — | ||
| Q2 25 | $245.6M | — | ||
| Q1 25 | $248.0M | — | ||
| Q4 24 | $250.4M | — | ||
| Q3 24 | $252.8M | — | ||
| Q2 24 | $254.0M | — | ||
| Q1 24 | $255.1M | — |
| Q4 25 | $-47.0M | $-80.0M | ||
| Q3 25 | $-48.5M | $9.2M | ||
| Q2 25 | $-53.7M | $151.3M | ||
| Q1 25 | $-31.7M | $144.2M | ||
| Q4 24 | $-32.6M | $255.0M | ||
| Q3 24 | $-49.8M | $346.8M | ||
| Q2 24 | $-45.7M | $432.4M | ||
| Q1 24 | $-9.7M | $140.3M |
| Q4 25 | $691.4M | $1.5B | ||
| Q3 25 | $611.7M | $1.2B | ||
| Q2 25 | $590.7M | $1.3B | ||
| Q1 25 | $592.9M | $1.3B | ||
| Q4 24 | $621.0M | $1.5B | ||
| Q3 24 | $549.9M | $1.5B | ||
| Q2 24 | $554.6M | $1.6B | ||
| Q1 24 | $595.4M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $270.0K | $-100.8M |
| 自由现金流率自由现金流/营收 | 0.1% | -48.6% |
| 资本支出强度资本支出/营收 | 0.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $59.6M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $1.1M | $-99.8M | ||
| Q3 25 | $18.7M | $-91.4M | ||
| Q2 25 | $-1.9M | $-108.3M | ||
| Q1 25 | $45.0M | $-166.5M | ||
| Q4 24 | $13.9M | $-79.3M | ||
| Q3 24 | $-8.2M | $-67.0M | ||
| Q2 24 | $-17.6M | $-77.0M | ||
| Q1 24 | $18.9M | $-190.7M |
| Q4 25 | $270.0K | $-100.8M | ||
| Q3 25 | $18.1M | $-92.7M | ||
| Q2 25 | $-3.1M | $-110.7M | ||
| Q1 25 | $44.3M | $-167.8M | ||
| Q4 24 | $13.4M | $-79.5M | ||
| Q3 24 | $-8.6M | $-68.6M | ||
| Q2 24 | $-18.3M | $-79.0M | ||
| Q1 24 | $16.7M | $-193.9M |
| Q4 25 | 0.1% | -48.6% | ||
| Q3 25 | 9.7% | -58.0% | ||
| Q2 25 | -1.8% | -66.5% | ||
| Q1 25 | 26.6% | -120.5% | ||
| Q4 24 | 8.0% | -48.3% | ||
| Q3 24 | -5.6% | -49.2% | ||
| Q2 24 | -12.5% | -53.7% | ||
| Q1 24 | 11.1% | -178.2% |
| Q4 25 | 0.4% | 0.5% | ||
| Q3 25 | 0.3% | 0.8% | ||
| Q2 25 | 0.7% | 1.5% | ||
| Q1 25 | 0.4% | 1.0% | ||
| Q4 24 | 0.3% | 0.1% | ||
| Q3 24 | 0.2% | 1.2% | ||
| Q2 24 | 0.5% | 1.4% | ||
| Q1 24 | 1.5% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 2.39× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APPN
| Subscriptions Software And Support | $162.3M | 80% |
| Professional Services | $40.6M | 20% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
